These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39341979)

  • 1. Experimental Study of the Promotional Implications of Proprietary Prescription Drug Names.
    Peinado S; O'Donoghue AC; Betts KR; Paquin RS; Giombi K; Arnold JE; Kelly BJ; Davis C
    Ther Innov Regul Sci; 2024 Sep; ():. PubMed ID: 39341979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
    O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
    Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content.
    Boudewyns V; Betts KR; Johnson M; Paquin RS; O'Donoghue AC; Southwell BG
    Res Social Adm Pharm; 2021 Apr; 17(4):733-743. PubMed ID: 32792323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.
    Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ
    Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of involvement and ad type on attitudes toward direct-to-consumer advertising of prescription drugs.
    Limbu Y; Torres IM
    J Health Hum Serv Adm; 2009; 32(1):107-38. PubMed ID: 19558035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Method of Addressing Proprietary Name Similarity for US Prescription Drugs.
    Stockbridge MD; Taylor K
    Ther Innov Regul Sci; 2015 Jul; 49(4):524-529. PubMed ID: 30222425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for the comparative evaluation of pharmaceuticals.
    Zentner A; Velasco-Garrido M; Busse R
    GMS Health Technol Assess; 2005 Nov; 1():Doc09. PubMed ID: 21289930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence selection for a prescription drug's benefit-harm assessment: challenges and recommendations.
    Fain KM; Yu T; Li T; Boyd CM; Singh S; Puhan MA
    J Clin Epidemiol; 2016 Jun; 74():151-7. PubMed ID: 26939932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Proprietary Names by Prescribers When Prescribing Over-the-Counter (OTC) Drug Products.
    Tu CM
    Ther Innov Regul Sci; 2019 Jan; 53(1):132-137. PubMed ID: 29714596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.
    Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Aikin KJ
    J Health Commun; 2017 Feb; 22(2):171-181. PubMed ID: 28129069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs.
    Davis JJ
    J Health Commun; 2000; 5(4):349-69. PubMed ID: 11191018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care physicians' use of FDA-approved prescription drug labels.
    Sullivan HW; O'Donoghue AC; Aikin KJ
    J Am Board Fam Med; 2014; 27(5):694-8. PubMed ID: 25201939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis.
    Aikin KJ; Sullivan HW; Dolina S; Lynch M; Squiers LB
    J Med Internet Res; 2017 Jul; 19(7):e225. PubMed ID: 28676469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network predicting drug's anatomical therapeutic chemical code.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2013 May; 29(10):1317-24. PubMed ID: 23564845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presenting efficacy information in direct-to-consumer prescription drug advertisements.
    O'Donoghue AC; Sullivan HW; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2014 May; 95(2):271-80. PubMed ID: 24581929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumers' experience with and attitudes toward direct-to-consumer prescription drug promotion: a nationally representative survey.
    Aikin KJ; Sullivan HW; Berktold J; Stein KL; Hoverman VJ
    Health Mark Q; 2021; 38(1):1-11. PubMed ID: 34238134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease Information in Direct-to-Consumer Prescription Drug Print Ads.
    Aikin KJ; Sullivan HW; Betts KR
    J Health Commun; 2016; 21(2):228-39. PubMed ID: 26717304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Proprietary Names by Prescribers for Generic Products.
    Borders-Hemphill V; Chan IZ; Brown K; Rider B; Taylor K; Chai G
    Ther Innov Regul Sci; 2018 Mar; 52(2):256-260. PubMed ID: 29714516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW; Bang HK
    Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.